drugset / Trial / NCT00498173
Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism
Phase 3
Completed
60 enrolled
Massachusetts General Hospital
National Institute of Mental Health (NIMH) · collab
RandomizedSequentialTriple-blindTreatment
Summary
This study will evaluate the effectiveness of atomoxetine in treating children with attention deficit hyperactivity disorder symptoms associated with autistic disorder, Asperger's syndrome, and pervasive developmental disorder, not otherwise specified.
Timeline
- Start
- 2007-07
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 1.8 mg/kg | — |